Nixon Peabody Trust’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-850
Closed -$251K 178
2026
Q1
$251K Buy
850
+25
+3% +$7.43K 0.02% 144
2025
Q4
$225K Sell
825
-21
-2% -$5.71K 0.02% 152
2025
Q3
$229K Hold
846
0.02% 141
2025
Q2
$233K Sell
846
-62
-7% -$16.9K 0.02% 143
2025
Q1
$241K Buy
+908
New +$224K 0.02% 143

Other funds holding CME

Nixon Peabody Trust's CME Position: Q2 2026 in Review

Nixon Peabody Trust sold out of CME Group (CME) in Q2 2026, closing a stake of 850 shares — an estimated $251K sold.

Nixon Peabody Trust first reported a position in CME in Q1 2025 and held it in 5 quarters. The position peaked at $251K in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Nixon Peabody Trust reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Nixon Peabody Trust sold 850 CME Group shares in Q2 2026, an estimated $251K.
  • Nixon Peabody Trust first reported a position in CME Group in Q1 2025 and held it in 5 quarters.
  • Nixon Peabody Trust's CME Group position peaked at $251K in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.